Event

XTL BIOPHARMACEUTICALS LTD. (XTLB)

XTL BIOPHARMACEUTICALS LTD. (XTLB) Files Form 6-K

Business News

Merck & Company Inc (MRK)

KEYTRUDA® (pembrolizumab) PlusWELIREG® (belzutifan) Given as Adjuvant Therapy Reduced the Risk of Disease Recurrence or Death by 28% Compared to …

SEC News

Aoxin Q & M Dental Grp Limited (1D4)

Financial Statements and Related Announcement: Full Yearly Results


Company Report

MAIA Biotechnology Inc. (MAIA)

Understanding Clinical Trials - Part 1 of 2

FDA Approval

FDA approves LAMOTRIGINE from TORRENT

Final approval of ANDA #ANDA #217100 for LAMOTRIGINE. Decision date: 01/08/2026

About Us

The main activity of our team is the prompt receipt of open information from various sources in order to analyze the market reaction to this information.

Our strategies:

  • a combination of various open sources of information with the identification and use of those that provide information most quickly;
  • extracting information mainly by automatic means using artificial intelligence;
  • providing users with structured information with modern available development tools;
  • the use of approaches and tools of machine learning methods to identify the most important events that affect the market;